Dr. Barlow is a renowned expert in neuroscience and neurodegeneration, rare diseases, and clinical development of new therapies.
Prior to joining ESCAPE, Dr. Barlow served as CEO of the Parkinson's Institute and Clinical Center, an independent nonprofit organization providing research, clinical trials, and patient care for Parkinson's and related disorders. There, she led all aspects of basic research, clinical research, and clinical care, as well as partnerships with biotech and pharmaceutical companies. Before joining the Parkinson’s Institute, Dr. Barlow was acting Chief Medical Officer at Amicus Therapeutics and also was a co-founder, Chief Scientific Officer, and Chief Medical Officer of BrainCells, Inc. She also served as director of Molecular Neuroscience at Merck Research Laboratories.
Dr. Barlow received her MD from the University of Utah and completed her residency in internal medicine at The New York Hospital, Cornell Medical Center, and earned her PhD in molecular and developmental biology at the Karolinska Medical Nobel Institute in Stockholm, Sweden. She is an author of approximately 100 peer-reviewed research papers, review articles, and book chapters, and is an inventor on numerous patents.